Moreover, following NaBu treatment, many of the CRC-relevant genes monitored throughout the study, such as MYC and FOSL1 showed a 3 to 7-fold reduction in Kbu binding affinity in the normal cell line compared to the CRC cell line (Supplementary Fig. 14e-h). This evidence concerns the gene MYC and colorectal carcinoma.